AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32199488 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 600
Study 32812398 — intervention group
Group type: EXPERIMENTAL
Intervention: Women as first authors in articles reporting randomized controlled trials
Number of subjects: 7651
Study 32812398 — intervention group
Group type: EXPERIMENTAL
Intervention: Women as senior authors in articles reporting randomized controlled trials
Number of subjects: 7651
Study 32812398 — intervention group
Group type: EXPERIMENTAL
Intervention: Women as first authors in all articles
Number of subjects: 7651
Study 32812398 — intervention group
Group type: EXPERIMENTAL
Intervention: Women as senior authors in all articles
Number of subjects: 7651
Study 32812398 — intervention group
Group type: COMPARATOR
Intervention: Women as first and senior authors in randomized controlled trials
Number of subjects: 7651
Study 34255068 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced-nicotine-content cigarettes (RNCCs)
Number of subjects: 747
Study 34255068 — intervention group
Group type: COMPARATOR
Intervention: 15.8 mg/g nicotine cigarettes
Number of subjects: 747
Study 33861768 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal praziquantel (PZQ) treatment
Number of subjects: 295
Study 33861768 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 295
Study 32728226 — intervention group
Group type: EXPERIMENTAL
Intervention: Toric intraocular lenses (TIOLs) with a fixed 2.00 DC cylinder correction
Number of subjects: 77
Study 32728226 — intervention group
Group type: COMPARATOR
Intervention: Monofocal intraocular lenses (IOLs) with limbal relaxing incisions (LRI)
Number of subjects: 77
Study 35529261 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary collaborative extended care (observation group)
Number of subjects: 96
Study 35529261 — intervention group
Group type: COMPARATOR
Intervention: Evidence-based nursing (comparison group)
Number of subjects: 96
Study 33145632 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-surgical periodontal treatment
Number of subjects: 107
Study 34610164 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin needling with 100% trichloroacetic acid (TCA)
Number of subjects: 68
Study 34610164 — intervention group
Group type: COMPARATOR
Intervention: Skin needling with bleomycin
Number of subjects: 68
Study 34702443 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitriol 0.5 μg per os twice daily for three days before surgery
Number of subjects: 246
Study 34702443 — intervention group
Group type: COMPARATOR
Intervention: Control group (no calcitriol)
Number of subjects: 246
Study 36265502 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab (200 mg intravenously every 3 weeks for 17 cycles)
Number of subjects: 976
Study 36265502 — intervention group
Group type: COMPARATOR
Intervention: Placebo (intravenously every 3 weeks for 17 cycles)
Number of subjects: 976
Study 33940037 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean field model developed to capture disease dynamics in clustered networks.
Number of subjects: 0
Study 35385361 — intervention group
Group type: EXPERIMENTAL
Intervention: tofacitinib 5 or 10 mg BID
Number of subjects: 0
Study 35385361 — intervention group
Group type: COMPARATOR
Intervention: adalimumab 40 mg every other week
Number of subjects: 0
Study 35385361 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study 32044505 — intervention group
Group type: EXPERIMENTAL
Intervention: PGE1 treatment (intravenous injection)
Number of subjects: 60
Study 32044505 — intervention group
Group type: COMPARATOR
Intervention: Regular therapy (control group)
Number of subjects: 60
Study 36214628 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist-supported acceptance and commitment therapy-based bibliotherapy (bi-weekly therapist support)
Number of subjects: 16
Study 36214628 — intervention group
Group type: COMPARATOR
Intervention: Therapist contact only (baseline phase)
Number of subjects: 16
Study 36214628 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist-supported bibliotherapy (intervention phase)
Number of subjects: 16
Study 35650554 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine infusion (load dose 0.5 μg kg−1 over 10 min, followed by maintenance dose 0.2 μg kg−1 h−1)
Number of subjects: 110
Study 35650554 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 110
Study 32618692 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-assisted reflection
Number of subjects: 40
Study 32618692 — intervention group
Group type: COMPARATOR
Intervention: Recall-assisted reflection
Number of subjects: 40
Study 35142407 — intervention group
Group type: EXPERIMENTAL
Intervention: synTOF
Number of subjects: 377
Study 35142407 — intervention group
Group type: COMPARATOR
Intervention: PETRA
Number of subjects: 377
Study 35142407 — intervention group
Group type: COMPARATOR
Intervention: TOF
Number of subjects: 377
Study 35142407 — intervention group
Group type: COMPARATOR
Intervention: synTOF vs TOF
Number of subjects: 377
Study 33367763 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic saline
Number of subjects: 40
Study 33367763 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline
Number of subjects: 40
Study 34916855 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine A (CsA) administered 2 weeks after fertilization for 6 months
Number of subjects: 0
Study 34916855 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered 2 weeks after fertilization for 6 months
Number of subjects: 0
Study 34384282 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral maraviroc (MVC) 300 mg dosed orally
Number of subjects: 20
Study 34384282 — intervention group
Group type: EXPERIMENTAL
Intervention: MVC 1% gel dosed rectally
Number of subjects: 20
Study 34384282 — intervention group
Group type: EXPERIMENTAL
Intervention: MVC 1% gel dosed vaginally
Number of subjects: 20
Study 34384282 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 20
Study 33470602 — intervention group
Group type: EXPERIMENTAL
Intervention: Rest Redistribution (RR)
Number of subjects: 45
Study 33470602 — intervention group
Group type: COMPARATOR
Intervention: Traditional Sets (TS)
Number of subjects: 45
Study 36200403 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailed brochure about BZRA risks and information about a free, online cognitive behavioral therapy for insomnia (CBTI) program (Arm 1)
Number of subjects: 2009
Study 36200403 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailed brochure about BZRA risks and telephone reinforcement call (Arm 2)
Number of subjects: 2009
Study 36200403 — intervention group
Group type: COMPARATOR
Intervention: Mailed brochure without insomnia treatment information (Arm 3)
Number of subjects: 2009
Study 34130954 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel community-based group exercise and nutritional intervention (protein supplementation) for 8 weeks
Number of subjects: 0
Study 35931131 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacrospinous hysteropexy with graft
Number of subjects: 173
Study 35931131 — intervention group
Group type: COMPARATOR
Intervention: Vaginal hysterectomy with uterosacral suspension
Number of subjects: 173
Study 35931131 — intervention group
Group type: EXPERIMENTAL
Intervention: Body mass index increase of 5 kg/m2
Number of subjects: 173
Study 35931131 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of prolapse symptoms increase of 1 year
Number of subjects: 173
Study 35931131 — intervention group
Group type: EXPERIMENTAL
Intervention: Women with obesity
Number of subjects: 173
Study 35931131 — intervention group
Group type: EXPERIMENTAL
Intervention: Women who are overweight
Number of subjects: 173
Study 35931131 — intervention group
Group type: EXPERIMENTAL
Intervention: Women experiencing >5 years of prolapse symptoms
Number of subjects: 173
Study 35449399 — intervention group
Group type: EXPERIMENTAL
Intervention: POC rapid CYP2C19 genotyping
Number of subjects: 5302
Study 35449399 — intervention group
Group type: COMPARATOR
Intervention: No genotyping (control)
Number of subjects: 5302
Study 32842399 — intervention group
Group type: EXPERIMENTAL
Intervention: Vacuum sealing drainage (VSD)
Number of subjects: 60
Study 33009189 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevel facing cephalad direction
Number of subjects: 68
Study 33009189 — intervention group
Group type: COMPARATOR
Intervention: Bevel facing left (conventional group)
Number of subjects: 68
Study 33380922 — intervention group
Group type: EXPERIMENTAL
Intervention: Distal transradial artery (dTRA) approach
Number of subjects: 900
Study 33380922 — intervention group
Group type: COMPARATOR
Intervention: Conventional transradial artery (TRA) approach
Number of subjects: 900
Study 36473974 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini-invasive canaliculotomy (minor incision 3 mm)
Number of subjects: 108
Study 36473974 — intervention group
Group type: COMPARATOR
Intervention: Conventional canaliculotomy (long incision 6–8 mm)
Number of subjects: 108
Study 33549761 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression status
Number of subjects: 347
Study 33549761 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression severity
Number of subjects: 347
Study 33549761 — intervention group
Group type: EXPERIMENTAL
Intervention: Body mass index (BMI)
Number of subjects: 347
Study 33549761 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate alcohol consumption
Number of subjects: 347
Study 33861375 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone 1 mg/kg/day (low dose)
Number of subjects: 60
Study 33861375 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone 2 mg/kg/day (standard dose)
Number of subjects: 60
Study 33861375 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study 32700415 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent Pneumatic Compression (IPC)
Number of subjects: 448
Study 32700415 — intervention group
Group type: COMPARATOR
Intervention: IPC with enoxaparin
Number of subjects: 448
Study 35550642 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard major trauma centre care plus REBOA
Number of subjects: 120
Study 35550642 — intervention group
Group type: COMPARATOR
Intervention: Standard major trauma centre care alone
Number of subjects: 120
Study 34724640 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine Learning (ML) algorithms - Random Forest Classifier (RFC)
Number of subjects: 964
Study 34724640 — intervention group
Group type: COMPARATOR
Intervention: Nomogram
Number of subjects: 964
Study 32975909 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA 50 mg/d
Number of subjects: 46
Study 32975909 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 36351794 — intervention group
Group type: EXPERIMENTAL
Intervention: Very early invasive coronary angiography (ICA) within 12 hours of diagnosis
Number of subjects: 452
Study 36351794 — intervention group
Group type: COMPARATOR
Intervention: Standard invasive coronary angiography (ICA) within 48-72 hours of diagnosis
Number of subjects: 452
Study 34181468 — intervention group
Group type: EXPERIMENTAL
Intervention: Top-Down Approach (initial DMSA scan)
Number of subjects: 500
Study 34181468 — intervention group
Group type: COMPARATOR
Intervention: Bottom-Up Approach (initial VCUG)
Number of subjects: 500
Study 32527966 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking at speeds of 0.89, 1.12, 1.34, 1.56, 1.79, 2.01, 2.24, and 2.46 m/s for 3 minutes
Number of subjects: 11
Study 32527966 — intervention group
Group type: EXPERIMENTAL
Intervention: Running at speeds of 1.79, 2.01, 2.24, 2.46, 2.68, 2.91, 3.13, and 3.35 m/s for 3 minutes
Number of subjects: 11
Study 32527966 — intervention group
Group type: COMPARATOR
Intervention: Comparison of lower limb attractor stability and sacrum displacement
Number of subjects: 11
Study 35388512 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent general practice intervention (enrolment with preferred GP, longer appointments, follow-up within 7 days of care episodes)
Number of subjects: 1044
Study 35388512 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent general practice intervention
Number of subjects: 1044
Study 35388512 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1044
Study 34716753 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan (0.1 μg/kg/min as a continuous 24‐h intravenous infusion administered once monthly for 1 year)
Number of subjects: 97
Study 34716753 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 97
Study 34716753 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study 34671856 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative systemic inflammatory response biomarkers (SIR-biomarkers) including albumin-globulin ratio (AGR), De Ritis ratio (DRR), and systemic immune-inflammation index (SII).
Number of subjects: 613
Study 34671856 — intervention group
Group type: EXPERIMENTAL
Intervention: High levels of SII and DRR in the testing cohort.
Number of subjects: 613
Study 34671856 — intervention group
Group type: COMPARATOR
Intervention: Exclusion of SIR-biomarkers from the model.
Number of subjects: 613
Study 34169923 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile voice call reminders on the second and seventh day after referral
Number of subjects: 310
Study 34169923 — intervention group
Group type: COMPARATOR
Intervention: Conventional paper-based referral
Number of subjects: 310
Study 33687835 — intervention group
Group type: EXPERIMENTAL
Intervention: Part-aware approach for joint part-level car parsing and reconstruction; Dense part information introduced to facilitate pose and shape estimation; Optimized with a novel 3D loss.
Number of subjects: 348
Study 33687835 — intervention group
Group type: EXPERIMENTAL
Intervention: Fusing dense part information for pose and shape estimation.
Number of subjects: 348
Study 33641770 — intervention group
Group type: EXPERIMENTAL
Intervention: Wellness Incentives and Navigation (WIN) intervention
Number of subjects: 0
Study 33641770 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 35383556 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS (2mA, 20 minutes, 3 days)
Number of subjects: 20
Study 35383556 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 20
Study 32028464 — intervention group
Group type: EXPERIMENTAL
Intervention: Sport-Specific (SS) resistance-band training
Number of subjects: 28
Study 32028464 — intervention group
Group type: COMPARATOR
Intervention: General-Training (GT) resistance-band training
Number of subjects: 28
Study 32971449 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led positive psychology intervention
Number of subjects: 91
Study 32971449 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 91
Study 35146942 — intervention group
Group type: EXPERIMENTAL
Intervention: Simplified dietary self-monitoring of high-calorie foods
Number of subjects: 72
Study 35146942 — intervention group
Group type: COMPARATOR
Intervention: Standard calorie monitoring
Number of subjects: 72
Study 34111870 — intervention group
Group type: EXPERIMENTAL
Intervention: Early-Treated (ET) group
Number of subjects: 50
Study 34111870 — intervention group
Group type: COMPARATOR
Intervention: Early-Untreated (EUT) group
Number of subjects: 50
Study 34111870 — intervention group
Group type: EXPERIMENTAL
Intervention: Full cohort (ET + EUT combined)
Number of subjects: 50
Study 32611631 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium channel blockers
Number of subjects: 757601
Study 32611631 — intervention group
Group type: COMPARATOR
Intervention: β-blockers
Number of subjects: 757601
Study 32611631 — intervention group
Group type: COMPARATOR
Intervention: Genetic predisposition to higher systolic and diastolic BP
Number of subjects: 757601
Study 35918813 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy
Number of subjects: 43
Study 35918813 — intervention group
Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 43
Study 32768272 — intervention group
Group type: EXPERIMENTAL
Intervention: Kangaroo care
Number of subjects: 64
Study 32768272 — intervention group
Group type: COMPARATOR
Intervention: Oral sucrose
Number of subjects: 64
Study 35435492 — intervention group
Group type: EXPERIMENTAL
Intervention: Polished with polishing rubbers
Number of subjects: 4
Study 35435492 — intervention group
Group type: EXPERIMENTAL
Intervention: Glaze application - powder/liquid technique
Number of subjects: 4
Study 35435492 — intervention group
Group type: EXPERIMENTAL
Intervention: Polished with polishing rubbers + glaze application - powder/liquid
Number of subjects: 4
Study 35435492 — intervention group
Group type: COMPARATOR
Intervention: As-sintered (control)
Number of subjects: 4
Study 33793794 — intervention group
Group type: EXPERIMENTAL
Intervention: Septum resection
Number of subjects: 80
Study 33793794 — intervention group
Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 80
Study 32867995 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacillus direct-fed microbial (DFM)
Number of subjects: 50
Study 32867995 — intervention group
Group type: COMPARATOR
Intervention: Control rye-based diet
Number of subjects: 50
Study 36452128 — intervention group
Group type: EXPERIMENTAL
Intervention: Subfascial ultrasound-guided stellate ganglion block
Number of subjects: 50
Study 36452128 — intervention group
Group type: COMPARATOR
Intervention: Extrafascial ultrasound-guided stellate ganglion block
Number of subjects: 50
Study 34379337 — intervention group
Group type: EXPERIMENTAL
Intervention: Sofosbuvir (SOF) plus Daclatasvir (DCV)
Number of subjects: 120
Study 34379337 — intervention group
Group type: EXPERIMENTAL
Intervention: Sofosbuvir (SOF) plus Ravidasvir (RDV)
Number of subjects: 120
Study 34379337 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 120
Study 32735427 — intervention group
Group type: EXPERIMENTAL
Intervention: Instant feedback group
Number of subjects: 25
Study 32735427 — intervention group
Group type: COMPARATOR
Intervention: Nonfeedback group
Number of subjects: 25
Study 35472247 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-led intervention (counselling intervention including drug information and answering queries)
Number of subjects: 165
Study 35472247 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-led intervention
Number of subjects: 165
Study 33856395 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous acetaminophen (1 g every 6 hours for 48 hours)
Number of subjects: 358
Study 33856395 — intervention group
Group type: COMPARATOR
Intervention: Placebo (1 g every 6 hours for 48 hours)
Number of subjects: 358
Study 33856395 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous acetaminophen
Number of subjects: 358
Study 33856395 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 358
Study 33208583 — intervention group
Group type: EXPERIMENTAL
Intervention: Goreisan for 3 months (Group G)
Number of subjects: 224
Study 33208583 — intervention group
Group type: COMPARATOR
Intervention: No medication (Group N)
Number of subjects: 224
Study 33208583 — intervention group
Group type: EXPERIMENTAL
Intervention: Goreisan for 3 months (Group G) in high-risk patients
Number of subjects: 224
Study 33208583 — intervention group
Group type: COMPARATOR
Intervention: No medication (Group N) in high-risk patients
Number of subjects: 224
Study 32584467 — intervention group
Group type: EXPERIMENTAL
Intervention: Deterministic probability-matching strategy
Number of subjects: 3
Study 32584467 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized probability-matching strategy
Number of subjects: 3
Study 32584467 — intervention group
Group type: COMPARATOR
Intervention: Nonadaptive strategy (equal allocation)
Number of subjects: 3
Study 36443869 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based cognitive behavioral therapy for insomnia (gCBT-I)
Number of subjects: 21
Study 36443869 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 21
Study 34116031 — intervention group
Group type: EXPERIMENTAL
Intervention: EUS-FNB with ROSE
Number of subjects: 800
Study 34116031 — intervention group
Group type: COMPARATOR
Intervention: EUS-FNB without ROSE
Number of subjects: 800
Study 32435764 — intervention group
Group type: EXPERIMENTAL
Intervention: EQUIA Forte (glass hybrid restorative system)
Number of subjects: 360
Study 32435764 — intervention group
Group type: COMPARATOR
Intervention: Tetric EvoCeram (nanohybrid resin composite)
Number of subjects: 360
Study 35448974 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT) for 12 weeks, coupled with Behavioral Activation techniques, meeting twice/week.
Number of subjects: 50
Study 35448974 — intervention group
Group type: COMPARATOR
Intervention: Attention-control group (Health, Wellness, and Education; HWE) for 12 weeks, meeting twice/week.
Number of subjects: 50
Study 32991513 — intervention group
Group type: EXPERIMENTAL
Intervention: Braces designed using CAD/CAM (CAD)
Number of subjects: 120
Study 32991513 — intervention group
Group type: EXPERIMENTAL
Intervention: Braces designed using CAD/CAM with finite element modeling (CAD-FEM)
Number of subjects: 120
Study 32991513 — intervention group
Group type: COMPARATOR
Intervention: Both CAD and CAD-FEM braces
Number of subjects: 120
Study 33342450 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual Placement Support (IPS)
Number of subjects: 720
Study 33342450 — intervention group
Group type: EXPERIMENTAL
Intervention: IPS supplemented with cognitive remediation (IPSE)
Number of subjects: 720
Study 33342450 — intervention group
Group type: COMPARATOR
Intervention: Service as Usual (SAU)
Number of subjects: 720
Study 33450366 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT (High-Intensity Interval Training)
Number of subjects: 69
Study 33450366 — intervention group
Group type: COMPARATOR
Intervention: MICE (Moderate-Intensity Continuous Exercise)
Number of subjects: 69
Study 33634552 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination oral clindamycin plus rifampicin (C + R)
Number of subjects: 36
Study 33634552 — intervention group
Group type: COMPARATOR
Intervention: Oral clindamycin monotherapy (CM)
Number of subjects: 36
Study 33044376 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone-iodine (PVP-I) irrigation
Number of subjects: 175
Study 33044376 — intervention group
Group type: COMPARATOR
Intervention: Sterile saline (SS) irrigation
Number of subjects: 175
Study 33044376 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk subjects
Number of subjects: 175
Study 33044376 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-risk subjects
Number of subjects: 175
Study 34919488 — intervention group
Group type: EXPERIMENTAL
Intervention: MEPP-website
Number of subjects: 10